Acura Pharmaceuticals ACUR Stock
Acura Pharmaceuticals Price Chart
Acura Pharmaceuticals ACUR Financial and Trading Overview
| Acura Pharmaceuticals stock price | 0.0028 USD |
| Previous Close | 0.05 USD |
| Open | 0.05 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.05 - 0.05 USD |
| 52 Week Range | 0.01 - 0.52 USD |
| Volume | 13.2K USD |
| Avg. Volume | 6.27K USD |
| Market Cap | 3.25M USD |
| Beta (5Y Monthly) | 2.303521 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.02 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
ACUR Valuation Measures
| Enterprise Value | 3.49M USD |
| Trailing P/E | N/A |
| Forward P/E | 0.13513513 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.4496436 |
| Price/Book (mrq) | 25 |
| Enterprise Value/Revenue | 1.554 |
| Enterprise Value/EBITDA | -3.375 |
Trading Information
Acura Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 2.303521 |
| 52-Week Change | -88.63% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.52 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.05 USD |
| 200-Day Moving Average | 0.04 USD |
ACUR Share Statistics
| Avg. Volume (3 month) | 6.27K USD |
| Avg. Daily Volume (10-Days) | 2.08K USD |
| Shares Outstanding | 65.09M |
| Float | 61.03M |
| Short Ratio | 0.73 |
| % Held by Insiders | 5.58% |
| % Held by Institutions | 3.00% |
| Shares Short | 89.85K |
| Short % of Float | 1.19% |
| Short % of Shares Outstanding | 0.76% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:5 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2020 |
| Most Recent Quarter (mrq) | September 30, 2021 |
| Next Fiscal Year End | December 31, 2021 |
Profitability
| Profit Margin | -51.26% |
| Operating Margin (ttm) | -49.35% |
| Gross Margin | 28.28% |
| EBITDA Margin | -46.057% |
Management Effectiveness
| Return on Assets (ttm) | -38.41% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 2.25M USD |
| Revenue Per Share (ttm) | 0.05 USD |
| Quarterly Revenue Growth (yoy) | -34.10% |
| Gross Profit (ttm) | 1.79M USD |
| EBITDA | -1034000 USD |
| Net Income Avi to Common (ttm) | -1151000 USD |
| Diluted EPS (ttm) | -0.03 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 89K USD |
| Total Cash Per Share (mrq) | 0.001 USD |
| Total Debt (mrq) | 324K USD |
| Total Debt/Equity (mrq) | 240 USD |
| Current Ratio (mrq) | 0.862 |
| Book Value Per Share (mrq) | 0.002 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -396000 USD |
| Levered Free Cash Flow (ttm) | -410500 USD |
Profile of Acura Pharmaceuticals
| Country | United States |
| State | IL |
| City | Palatine |
| Address | 616 N. North Court |
| ZIP | 60067 |
| Phone | 847 705 7709 |
| Website | https://www.acurapharm.com |
| Industry | Drug Manufacturers-Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 12 |
Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was incorporated in 1935 and is based in Palatine, Illinois.
Q&A For Acura Pharmaceuticals Stock
What is a current ACUR stock price?
Acura Pharmaceuticals ACUR stock price today per share is 0.0028 USD.
How to purchase Acura Pharmaceuticals stock?
You can buy ACUR shares on the Other OTC exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Acura Pharmaceuticals?
The stock symbol or ticker of Acura Pharmaceuticals is ACUR.
Which industry does the Acura Pharmaceuticals company belong to?
The Acura Pharmaceuticals industry is Drug Manufacturers-Specialty & Generic.
How many shares does Acura Pharmaceuticals have in circulation?
The max supply of Acura Pharmaceuticals shares is 66M.
What is Acura Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Acura Pharmaceuticals PE Ratio is now.
What was Acura Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Acura Pharmaceuticals EPS is -0.02 USD over the trailing 12 months.
Which sector does the Acura Pharmaceuticals company belong to?
The Acura Pharmaceuticals sector is Healthcare.
Acura Pharmaceuticals ACUR included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite Total Return I XCMP | 19659.36 USD — |
-1.62
|
— — | 19598.88 USD — | 19861.56 USD — | — - | — — |
- {{ link.label }} {{link}}